Analgesics - Lesotho | Statista Market Forecast

In Lesotho, the revenue generated in the Analgesics market in 2024 amounts to US$803.20k.
It is projected to experience an annual growth rate of 6.75% (CAGR 2024-2029).
Comparatively, the United States generates the highest revenue globally, with a total of US$7.24bn in 2024.
When considering the per person revenues in relation to the total population, in Lesotho generates US$0.34 in 2024.
The demand for analgesics in Lesotho is rising due to an increasing prevalence of chronic pain conditions among the population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Lesotho is experiencing steady growth due to several factors.

Customer preferences: Customers in Lesotho have shown a growing preference for analgesics as a means to manage pain and discomfort. This is largely driven by the increasing awareness about the importance of self-care and the need for quick relief from common ailments such as headaches, muscle aches, and joint pain. Additionally, the convenience and affordability of analgesics make them a popular choice among consumers in Lesotho.

Trends in the market: One of the key trends in the Analgesics market in Lesotho is the rising demand for over-the-counter (OTC) analgesics. OTC analgesics are easily accessible without a prescription and provide immediate relief from mild to moderate pain. This trend can be attributed to the growing preference for self-medication and the convenience of purchasing OTC analgesics from local pharmacies and supermarkets.Another trend in the market is the increasing demand for natural and herbal analgesics. Consumers in Lesotho are becoming more conscious about the potential side effects of synthetic analgesics and are seeking alternative options that are perceived to be safer and more sustainable. This has led to the introduction of herbal analgesics in the market, which are made from natural ingredients and are believed to have fewer side effects.

Local special circumstances: Lesotho is a landlocked country with a high altitude, which can contribute to certain health conditions such as headaches and muscle aches. The local climate and geographical conditions may increase the demand for analgesics among the population. Additionally, Lesotho has a growing middle class with increasing disposable income, which has led to higher healthcare expenditure and a greater willingness to purchase analgesics.

Underlying macroeconomic factors: The growing economy of Lesotho is contributing to the development of the Analgesics market. As the country's GDP continues to increase and more people enter the middle class, there is a greater ability and willingness to spend on healthcare products, including analgesics. Furthermore, the government of Lesotho has been implementing policies to improve healthcare infrastructure and access to medication, which has positively impacted the availability and affordability of analgesics in the market.In conclusion, the Analgesics market in Lesotho is growing steadily due to the preferences of customers for quick relief from common ailments, the increasing demand for OTC and natural analgesics, local special circumstances such as climate and altitude, and the underlying macroeconomic factors such as the growing economy and government initiatives.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.